Dr. Wido Tilmann

Dr. Wido Tilmann is a seasoned medical professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Medical Director DACH at Santhera Pharmaceuticals since January 2024, Dr. Tilmann previously held various positions at PTC Therapeutics, Inc., including Associate Medical Director Central Europe and Senior MSL Medical Affairs for Gene Therapy. Prior to that, roles at Leadiant GmbH and Sigma-tau enhanced expertise in medical scientific liaison activities. Dr. Tilmann initiated a career in business development at Parsagen Diagnostics GmbH and contributed as a scientific researcher at the University of Cologne, where a doctorate in general biology was obtained.